Cardiovascular Systems (CSII) Prelim. Q1 Results Miss Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BofA/Merrill Lynch Downgrades Cardiovascular Systems (CSII) to Underperform
October 8, 2015 7:45 AM EDTBofA/Merrill Lynch downgraded Cardiovascular Systems (NASDAQ: CSII) from Buy to Underperform with a price target of $15.00.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $16.63 yesterday.
... MoreNeedham & Company Downgrades Cardiovascular Systems (CSII) to Buy
October 8, 2015 7:37 AM EDTNeedham & Company downgraded Cardiovascular Systems (NASDAQ: CSII) from Strong Buy to Buy with a price target of $18.00 (from $37.00).
Analyst Mike Matson commented, "We are downgrading CSII to Buy from Strong Buy after last night's negative preannouncement. On one hand, we see... More
Leerink Partners Downgrades Cardiovascular Systems (CSII) to Market Perform
October 8, 2015 6:24 AM EDTLeerink Partners downgraded Cardiovascular Systems (NASDAQ: CSII) from Outperform to Market Perform with a price target of $17.00 (from $45.00) after the company preannounced weaker-than-expected F1Q16 sales driven by another quarter of salesforce disruption.
Analyst Danielle Antalffy commented, "Clearly the salesforce transition... More
